论文部分内容阅读
目的 对肝动脉化疗栓塞术 (TAE)进行死因分析。方法 收集行 TAE术的 2 81例肝癌患者 ,其中术后2个月内死亡 2 2例 ,对其死因进行分析。结果 死于肝功能衰竭 11例 ,上消化道出血 8例 ,肝癌破裂 2例 ,呼吸衰竭1例。结论 肝功能 C级 (Child A)不宜行 TAE,有门脉癌栓不宜行栓塞。肝功能 B级者宜待腹水、黄疸、转氨酶好转后再行 TAE术。术中尽可能血管超选。反复 TAE者间隔时间至少 1个月以上 ,并注意侧枝循环的形成 ,应加以栓塞化疗。
Objective To analyze the cause of death of transcatheter arterial chemoembolization (TAE). Methods A total of 2 81 liver cancer patients undergoing TAE were collected, of whom 22 died within 2 months after operation and their causes of death were analyzed. Results of death in 11 cases of liver failure, upper gastrointestinal bleeding in 8 cases, 2 cases of liver cancer rupture, respiratory failure in 1 case. Conclusion Liver function C (Child A) should not be TAE, a portal vein tumor thrombus should not embolism. Grade B liver function should be treated with ascites, jaundice, transaminase improved after TAE surgery. Intraoperative as much as possible vascular over-selection. Repeated TAE interval of at least 1 month or more, and pay attention to the formation of collateral circulation, should be embolized chemotherapy.